Skip to main content
. 2020 Jan 1;16(3):495–503. doi: 10.7150/ijbs.39582

Figure 3.

Figure 3

NKILA suppresses metastasis of HCC in vivo. (A) Representative images of lung sections stained by H&E in each group of SMMC-7721 cells. (B) The numbers of metastatic lesions in the lungs at 6 weeks after tail vein injection. **P < 0.01. OE, NKILA overexpression; NC, negative control.